Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies.

Lischka A. et al, (2023), Brain

Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study.

Bäckryd E. et al, (2023), Pain

GluCl.CreON enables selective inhibition of molecularly defined pain circuits.

Middleton SJ. et al, (2023), Pain

Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment.

Truini A. et al, (2023), Eur J Neurol

New perspectives in diabetic neuropathy.

Eid SA. et al, (2023), Neuron

Utilising clinical parameters to improve the selection of nerve biopsy candidates.

Kopanidis P. et al, (2023), Intern Med J

Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons

Kim HW. et al, (2023), Pain

Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study.

Hébert HL. et al, (2023), J Neurol, 270, 1076 - 1094

Electroencephalography functional connectivity-A biomarker for painful polyneuropathy.

Topaz LS. et al, (2023), Eur J Neurol, 30, 204 - 214

Inhibition of sensory neuron driven acute, inflammatory, and neuropathic pain using a humanised chemogenetic system

Sanchez JP. et al, (2023), bioRxiv

Acute small fiber neuropathy after Oxford-AstraZeneca ChAdOx1-S vaccination: A report of three cases and review of the literature.

Abbott MG. et al, (2022), J Peripher Nerv Syst, 27, 325 - 329

Maximizing treatment efficacy through patient stratification in neuropathic pain trials.

Baron R. et al, (2022), Nat Rev Neurol

Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a national cohort: ’NIHR Bioresources Rare Disease – Neuropathic Pain Disorders’

THEMISTOCLEOUS A. et al, (2022), Brain Communications

Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.

Tesfaye S. et al, (2022), Health Technol Assess, 26, 1 - 100

Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

Elafros MA. et al, (2022), The Lancet Neurology, 21, 922 - 936

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.

Tesfaye S. et al, (2022), Lancet

Shared genetic susceptibility between trigger finger and carpal tunnel syndrome: a genome-wide association study.

Patel B. et al, (2022), Lancet Rheumatol, 4, e556 - e565

Genetic pain loss disorders.

Lischka A. et al, (2022), Nat Rev Dis Primers, 8

Sodium-calcium exchanger-3 regulates pain "wind-up": From human psychophysics to spinal mechanisms.

Trendafilova T. et al, (2022), Neuron

Neuropathy and pain after breast cancer treatment: a prospective observational study.

Bennedsgaard K. et al, (2022), Scand J Pain

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?